Goldman Sachs Raises XPeng’s Price Target to $25

1 min read Reproduced verbatim
Rating
In-line
Unchanged
Target
$25
from $24 (+4%)
Upside
+160%
XPEV at $9.60 today
Goldman Sachs and XPeng logos

What the analyst said

Goldman Sachs analyst Tina Hou raised on November 19, 2025, the price target on XPeng to $25 (from $24) while maintaining a ‘Buy’ rating on the stock.

“XPeng ADR/H share price retreated 10%/10% post an in-line 3Q25 result, but below-expectation 4Q25E revenue guidance mainly from slowing volume growth (from 149% yoy in 3Q25 to 41% in 4Q25E) and continued competition in the market (First Take).

Although near-term sales momentum may be moderate with only few new model launches, looking into 1Q26E, we see XPeng having better seasonality vs. peers as the company will launch the EREV version of 3 models (G6/G7/P7+), which could potentially see 3X higher order vs. the BEV versions based on management comment for X9 EREV pre-order data.

For 2026E full year, we expect a strong new model pipeline and sustainable revenue contribution from VW to drive 40% revenue growth, improving gross margin from scale economics and continued cost-down, continued R&D investment and improving account payabledays, leading to GAAP net income of Rmb2.2bn (first full-year break-even).

Estimate changes

Post 3Q25 result, we lower our 2025E-27E earnings estimates from Rmb-0.4bn/3.8bn/5.5bn to Rmb-0.8bn/2.8bn/3.3bn mainly on higher R&D expenses into new businesses; on the other hand, changes in working capital increases to Rmb7.7bn/2.9bn/4.5bn from Rmb6.6bn/0.6bn/3.9bn on shorter account payable days.

After rolling forward DCF-valuation by 1 year, our 12-month target prices change to US$25/HK$96 (from US$24/HK$94 previously), implying +11%/+12% upside.

Maintain Buy rating.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

XPEV trades at $9.60. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $25 target is 56% above the median, the highest on the Street.

Since the note XPEV has moved −58% (from $22.62). 12-month window: day 351 of 365, closes on November 19, 2026.

Track record

This callOpen: XPEV has not reached $25 yet. This 12-month target is scored on November 19, 2026.

Firm track recordGoldman Sachs: 78% of its 37 targets at least a year old were reached within 12 months (#16 of 26 firms). Accuracy ranking →

Goldman Sachs on XPeng

Goldman Sachs price targets on XPeng

4 calls from November 19, 2025 to October 23, 2026. The target went from $25 to $16 (−36%). The rating moved from Hold to Buy.

Goldman Sachs targetXPEV share price
  1. October 23, 2026Target cut from $20 (−20%)Buy$16
  2. August 3, 2026Target cut from $22 (−9%)Buy$20
  3. February 12, 2026Upgraded to Buy, target cut from $25 (−12%)Buy$22
  4. November 19, 2025 This noteEarliest call shownHold$25
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.